A detailed history of Genus Capital Management Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Genus Capital Management Inc. holds 760 shares of ELV stock, worth $314,374. This represents 0.05% of its overall portfolio holdings.

Number of Shares
760
Previous 815 6.75%
Holding current value
$314,374
Previous $301 Million 9.95%
% of portfolio
0.05%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 30, 2025

BUY
$365.9 - $436.25 $278,084 - $331,550
760 New
760 $331 Million
Q1 2024

May 02, 2024

BUY
$464.61 - $519.96 $2.55 Million - $2.85 Million
5,484 New
5,484 $2.84 Billion
Q3 2023

Oct 31, 2023

BUY
$414.13 - $475.93 $39,342 - $45,213
95 Added 2.86%
3,418 $1.49 Billion
Q2 2023

Aug 11, 2023

BUY
$436.33 - $496.2 $1.45 Million - $1.65 Million
3,323 New
3,323 $1.48 Billion

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $99.3B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Genus Capital Management Inc. Portfolio

Follow Genus Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genus Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Genus Capital Management Inc. with notifications on news.